Welcome to our dedicated page for Scage Future news (Ticker: SCAG), a resource for investors and traders seeking the latest updates and insights on Scage Future stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Scage Future's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Scage Future's position in the market.
Scage Future (Nasdaq: SCAG) received a Nasdaq notice on June 11, 2026 for not meeting the US$1.00 minimum bid price under Listing Rule 5550(a)(2), after its ADSs closed below US$1.00 for 30 consecutive business days.
The company has 180 calendar days to regain compliance by achieving at least US$1.00 closing bid for 10 consecutive business days. Listing and operations remain unchanged for now, and Scage may consider actions such as a reverse share split.